The Improving Outcomes in Relapsed-Refractory Diffuse Large B Cell Lymphoma: The Role of CAR T-Cell Therapy.
| Publicado en: | Current Treatment Options in Oncology Vol. 26; no. 6; pp. 445 - 465 |
|---|---|
| Autores principales: | , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Jun2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=187261471&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 187261471 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15272729 3KHC jtl: Current Treatment Options in Oncology issn: 15272729 maglogo: N pubinfo: dt: Jun2025 vid: 26 iid: 6 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 187261471 184781874 10.1007/s11864-025-01305-9 187261471 ppf: 445 ppct: 20 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: The Improving Outcomes in Relapsed-Refractory Diffuse Large B Cell Lymphoma: The Role of CAR T-Cell Therapy. aug: au: Milunović, Vibor Dragčević, Dora Bogeljić Patekar, Martina Mandac Smoljanović, Inga Gašparov, Slavko affil: https://ror.org/01b6d9h22 Division of Hematology, Clinical Hospital Merkur, Zajčeva 19, 10000, Zagreb, Croatia sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|